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The aim of the present study was to evaluate the occult lymph node carcinomatous diffusion in head and neck squamous cell
carcinoma (HNSCC). A total of 1328 lymph nodes from 31 patients treated between 2004 and 2005 were prospectively evaluated
by routine haematoxylin–eosin–safran (HES) staining, immunohistochemistry (IHC) and real-time Taqman reverse–transcriptase
polymerase chain reaction (real-time RT–PCR) assay. Amplification of cytokeratin 19 (CK19) mRNA transcripts using real-time RT–
PCR was used to quantify cervical micrometastatic burden. The cervical lymph node metastatic rates determined by routine HES
staining and real-time RT–PCR assay were 16.3 and 36.0%, respectively (Po0.0001). A potential change in the nodal status was
observed in 13 (42.0%) of the 31 patients and an atypical pattern of lymphatic spread was identified in four patients (12.9%).
Moreover, CK19 mRNA expression values in histologically positive lymph nodes were significantly higher than those observed in
histologically negative lymph nodes (Po0.0001). These results indicate that real-time RT–PCR assay for the detection of CK19
mRNA is a sensitive and reliable method for the detection of carcinomatous cells in lymph nodes. This type of method could be used
to reassess lymph node status according to occult lymphatic spread in patients with HNSCC.
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The presence of metastatic cervical lymph nodes is a major
prognostic factor in patients with head and neck squamous cell
carcinoma (HNSCC) (Shores et al, 2004). Staging of cervical lymph
nodes, therefore critical, is usually limited to routine histologic
examination of only a few hematoxylin–eosin (HE)-stained
sections of each node (Barrera et al, 2003). Various reports have
demonstrated that such a routine analysis may fail to detect a
significant number of nodal metastases in lung and breast cancers
(International (Ludwig) Breast Cancer Study Group, 1990; Wu
et al, 2001). Regional recurrence rates of approximately 10% are
reported in patients with histologically negative neck dissection
specimens, suggesting that carcinomatous cells were present but
not detected in the resected nodes (Tu, 1999). In a recent report,
approximately 5–20% of HNSCC patients harboured occult
metastases not identified by routine histopathologic examination
but detected by other methods such as immunohistochemistry
(IHC) or molecular biology, that is, reverse transcriptase–
polymerase chain reaction (RT–PCR) (Hamakawa et al, 2000a;
Godfrey et al, 2001; Shores et al, 2004; Le Pimpec-Barthes et al,
2005).
Additional use of a molecular investigation, such as RT–PCR,
has been largely developed in various solid tumours to determine
the incidence of micrometastases missed during routine light
microscopy (Ambrosch and Brinck, 1996). However, some of these
molecular studies performed in HNSCC have been suspected to
have a low specificity (Kawamata et al, 1999; Hamakawa et al,
2000a). We therefore decided to design a method based on a real-
time Taqman PCR reverse–transcriptase polymerase chain reac-
tion (real-time RT–PCR) assay to detect cytokeratin 19 (CK19)
mRNA marker of occult tumour cells in lymph nodes of patients
undergoing neck dissection for HNSCC as such a marker has been
shown to detect accurately micrometastases in patients with lung,
oesophageal, gastric, breast or colorectal carcinoma (Izbicki et al,
1997; Czerniecki et al, 1999; Weitz et al, 1999; Gai et al, 2000;
Saintigny et al, 2005). Moreover CK19 has been demonstrated to be
a component of the cell cytoskeleton of HNSCC (Cohen-Kerem
et al, 2002; Welkoborsky et al, 2003) and can be considered to be
an appropriate marker of HNSCC carcinomatous cells.
The aim of this prospective study was therefore to develop a
quantitative CK19 mRNA RT–PCR assay for the detection and
quantification of occult micrometastases in cervical lymph nodes
collected during systematic neck dissection of HNSCC. We
hypothesised that the detection of carcinomatous lymph node
involvement using more sensitive methods than routine histo-
pathologic examination, such as real-time RT–PCR, could change
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sthe nodal status, as well as the patient’s subsequent treatment
regimens (Shores et al, 2004).
MATERIALS AND METHODS
Patients and neck dissection samples
This study, conducted according to the institutional and ethical
rules concerning research on tissue specimens, was exempted from
informed consent from the patients (CCPPRB Paris Pitie ´
Salpe ´trie `re). A prospective series of 31 patients with primary
squamous cell carcinoma of the oral cavity (n¼7, 22.6%),
oropharynx (n¼6, 19.4%), hypopharynx (n¼17, 54.8%) and
larynx (n¼1, 3.2%) who underwent surgical treatment including
unilateral or bilateral selective neck dissection between 2004 and
2005 at the Department of Otolaryngology Head and Neck Surgery
of Tenon hospital (Paris University VI) were entered in the present
study (Table 1). The average age of these patients was 59.579.3
year (range: 40–75 years). In these 31 patients, a total of 42
selective neck dissections (11 patients had bilateral dissections)
were performed, and 1328 lymph nodes (mean: 42.8720.6 nodes
per patient) were obtained from the neck dissection samples.
These 1328 lymph nodes were collected from 178 different groups
distributed at various levels according to the topographic
classification of neck nodes by Robbins et al (2002).
Lymph nodes, macroscopically isolated, were cut into 3mm
slices. The even-numbered slices were formalin-fixed (24-h in 20%
buffered-formalin) and paraffin-embedded for routine HE–safran
(HES) staining, and the odd-numbered slices were frozen in liquid
nitrogen and stored at  801C until RNA extraction. The entire
procedure after neck dissection to freezing was performed within
1h.
Control lymph nodes and peripheral blood mononuclear
cells (PBMNs)
In all, 17 lymph nodes were collected from patients undergoing
sigmoidectomy for sigmoid diverticulitis (n¼6) or elective carotid
endarterectomy (n¼11). None of these patients had a history or
clinical evidence of cancer. Five millilitres of blood from 29 healthy
volunteers were collected by venipuncture. Peripheral blood
mononuclear cells were isolated by density centrifugation on
Ficoll gradient (catalog number U04; UnisepþNovamed, Israel).
Control lymph nodes and blood mononuclear cells were processed
for RNA extraction.
Real-time RT–PCR assay
Frozen specimens from neck dissection lymph nodes, CAPAN-1
cell line (human pancreas adenocarcinoma cells) and PBMNs were
stored at  801C until RNA extraction. CAPAN-1 cell line, obtained
from the American Tissue Culture Collection (ATCC, Rockville,
MD, USA), was selected to standardise the CK19 mRNA marker
(Saintigny et al, 2005). The odd-numbered frozen sections of
lymph nodes from the same level according to the above-
mentioned topographic classification were pooled as a single
specimen for RNA extraction. Total RNA was extracted using the
Trizol reagent (Life Technology, Gaithersburg, MD, USA) and
purified according to the manufacturer’s instructions. The
quantity and quality of the extracted RNA were confirmed by
absorption spectrophotometry at 260 and 280nm. cDNA was
reverse-transcribed from 2mg of total RNA in a 20ml reaction mix
using the Moloney-Murine Leukemia Virus Superscript II RNase
H-Reverse Transcriptase Kit from Gibco-BRL (Invitrogen, Cergy-
Pontoise, France) according to the manufacturer’s instructions.
For CK19 mRNA detection, primers (Proligo Sigma, Paris,
France) and probe (MWG Biotechnology Ebersberg, Germany)
were designed to avoid the detection of the two known
pseudogenes (Rund et al, 1999; Van Trappen et al, 2001), and a
custom-labelled fluorescence probe was synthesised with FAM
(6-carboxyfluorescein) and TAMRA (6-carboxyltetramethylrhoda-
mine). CK19 (75bp) – forward primer: 5-TCG ACA ACG CCC GTC
TG-3, reverse primer: 5-CCA CGC TCA TGC GCA G-3, probe: 5-
(FAM)-CCG AAC CAA GTT TGA GAC GGA ACA GG-(TAMRA)-3.
We evaluated the use of human leucocyte class IC (HLAIC) as an
internal control (Rasmussen, 2001). Primers (Proligo Sigma, Paris,
France) for HLAIC mRNA detection and HLAIC probe (MWG
Biotechnology Ebersberg, Germany) were designed using Perkin-
Elmer Primer Express software with Proligo (Paris, France), and a
custom-labelled fluorescence probe was synthesised with HEX
(hexachloro-6-carboxyfluorescein) and TAMRA. Human leucocyte
class IC (63bp) – forward primer: 5-GGG TAT GAC CAG TCC
GCC T-3, reverse primer: 5-GGA GCG CAG GTC CTC GTT-3,
probe: 5-(HEX)-CGA CGG CAA GGA TTA CAT CGC CCT-
(TAMRA)-3. The specificities of primers and probe sequences
were confirmed by BLAST analysis (www.ncbi.nlm.nih.gov/
BLAST/).
Real-time RT–PCR assays were carried out using a 25ml
reaction mix on the iCycler iQ (Bio-Rad, Hercules, CA, USA)
Taqman chemistry system including 5ml of 20-fold diluted total
reverse transcription reaction mix, 300nM of forward primer,
reverse primer and 200nM of probe, 12.5ml of Taqman PCR Master
Mix (Applied Biosystems, Foster City, CA, USA) and sterile water.
Thermocycler conditions were 10min at 951C before 40 cycles at
951C for 15s and at 601C for 60s (two-step reaction). Each
amplification was performed in triplicate, with a negative control
(absence of cDNA) and a positive control (cDNA of the standard
for the mRNA tested). The parameter threshold cycle (Ct)i s
defined as the fractional cycle number at which the fluorescence
generated by cleavage of the probe exceeds a fixed threshold above
baseline. Lymph node levels were considered to be positive when
all triplicates were positive for CK19 mRNA and when the internal
control was amplified within the usual range.
The standard curve was plotted for each reaction using four
10-fold serial dilutions of standard cDNA, and the amplification
efficiency (AE) was calculated using Bio-Rad software (Bio-Rad,
Hercules, CA, USA) according to the following equation:
AE¼10
 1/m, where m is the slope of the line determined by the
four dilutions of standard cDNA for the marker tested. The PCR
reaction was linear from the first dilution to the fourth dilution of
all standards (Figure 1). The best standard was defined by the
Table 1 Characteristics of patients with HNSCC
Patients Oral cavity Oropharynx Hypopharynx Larynx
Number 7 6 17 1
Age 55.775.7 69.075.5 57.479.7 64
Gender
Male 5 5 14 0
Female 2 1 3 1
T stage
T1–2 6 6 10 0
T3–4 1 0 7 1
N stage
N0 3 3 8 1
N1–3 4 3 9 0
Lymph nodes
Total (%)
a 301 (22.7%) 226 (17.0%) 755 (56.9%) 46 (3.4%)
Positive (HES)
b 6 (2.0%) 2 (0.9%) 25 (3.3%) 0 (0%)
HES¼haematoxylin–eosin–safran; HNSCC¼head and neck squamous cell
carcinoma.
a% of all lymph nodes collected.
bAfter usual histopathologic examination.
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sclosest expression level between the mRNA marker and the
internal control and by an AE for the CK19 mRNA marker and
internal control greater than 90%. Quantitation of mRNA relative
to the standard level of expression of the genes of interest was
defined as a relative quantity (RQ) and was given by the following
equation (Livak and Schnittgen, 2001): RQ ¼ð 1 þ AEÞ
 DDCt, where
DDCt¼¼((Ctgene of interest Ctinternal control)sample (Ctgene of interest
 Ct internal control)standard).
Immunohistochemistry
Immunohistochemistry was performed on 4mm sections of
formalin-fixed, paraffin-embedded samples from 203 lymph nodes,
negative after HES staining and in which CK19 mRNA was
detected by real-time RT–PCR assay and, as controls, on five HES-
positive lymph nodes. Immunostaining was carried out using the
Ventana immunostainer automatic protocol (Saintigny et al, 2005)
with pancytokeratin antibody (AE1/AE3, Dako Cytomation M3515,
diluted to 1:100).
Statistical analysis
Categorical variables were compared using the w
2 test. Continuous
variables were compared using the Mann–Whitney U-test. All
P-values were two-sided. Differences were considered significant
for Po0.05. These statistical analyses were performed using SPSS
version 11.0 software.
RESULTS
Histopathologic examination
Metastatic carcinomatous cells were observed after HES staining in
33 (2.5%) of the 1328 lymph nodes. The frequencies of nodal
metastases were 2.0% (six of 301) in the oral cavity, 0.9% (two of
226) in the oropharynx, 3.3% (25 of 755) in the hypopharynx and
0% (zero of 46) in the larynx (Table 1). Of the 178 cervical lymph
node levels, 29 (16.3%) investigated were considered to be
metastatic. The details of these results are presented in Table 2.
Real-time RT–PCR assay
No amplification product was observed when no template was
added. The amplified products obtained from RNA extracted from
CAPAN-1 cell line for CK19 and HLAIC show the expected bands
(75 and 63bp) after agarose gel electrophoresis (data not shown).
CK19 mRNA was not detected in either PBMN samples from
healthy subjects or in RNA extracted from the 17 lymph nodes
collected from patients without cancer (data not shown). Human
leukocyte class IC expressed in histopathologically negative lymph
nodes (Ct¼24.7871.05) close to the levels observed in histo-
pathologically positive lymph nodes (Ct¼24.3571.25) has been
demonstrated to be a particularly accurate internal control
(P40.05).
CK19 mRNA was detected in 236 lymph nodes from 64 lymph
node levels; 203 of these lymph nodes were negative after
histopathology examination. Detailed results of CK19 mRNA
detection by real-time RT–PCR according to tumour site are
shown in Table 2. Real-time RT–PCR gave a positive signal in
36.0% of all lymph node levels, while histopathology detected
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Figure 1 Amplification of CK19 mRNA by real-time RT–PCR assay
(iCycler iQ). (A) Amplification plots of four 10-fold serial dilutions of the
standard CK19 mRNA from CAPAN-1 cells total RNA. The initial amount
of total mRNA is displayed: 2.5 10
4, 2.5 10
3, 2.5 10
2 and 25pg.
Threshold cycle (Ct) is calculated as the cycle at which fluorescence signal
exceeds a fixed threshold line. (B) Standard curve of real-time RT–PCR
CK19 assay. Ct is plotted against the starting quantity of CAPAN-1 cell total
RNA.
Table 2 Results of histopathologic examination and CK19 mRNA real-time RT–PCR in the various cervical lymph node levels expressed as the number
of positive levels/total number of levels investigated
Oral cavity Oropharynx Hypopharynx Larynx All tumours
Lymph node levels
a HES RT–PCR HES RT–PCR HES RT–PCR HES RT–PCR HES RT–PCR
Level I 2/10 4/10 0/2 0/2 0/0 0/0 0/0 0/0 2/12 4/12
Level IIa 1/9 5/9 1/5 1/5 9/24 12/24 0/2 0/2 12/40 18/40
Level IIb 0/9 7/9 0/7 2/7 5/23 9/23 0/2 0/2 6/41 18/41
Level III 0/9 2/9 0/7 1/7 6/24 8/24 0/2 0/2 6/42 11/42
Level IV 0/7 2/7 0/7 2/7 1/23 7/23 0/2 0/2 1/39 11/39
Level V 0/0 0/0 1/1 1/1 1/2 1/2 0/0 0/0 2/3 2/3
Level VI 0/0 0/0 0/0 0/0 0/1 0/1 0/0 0/0 0/1 0/1
Total 5/44 20/44 2/29 7/29 22/97 37/97 0/8 0/8 29/178 64/178
% 11.4 45.5 6.9 24.1 22.7 38.1 0 0 16.3
b 36.0
b
CK19¼cytokeratin 19; HES¼haematoxylin–eosin–safran; RT–PCR¼reverse transcriptase–polymerase chain reaction.
aNeck dissection samples have been categorised
according to the topographic classification of cervical lymph node levels proposed by Robbins et al (2002).
bDifference between HES and real-time RT–PCR results, Po0.0001.
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scarcinomatous cells in 16.3% of lymph node levels. On the basis of
these results, molecular analysis using real-time RT–PCR for CK19
mRNA detection gave significantly different results from routine
histopathologic examination (Po0.0001).
Individual results per patient are shown in Table 3 for patients
who underwent unilateral neck dissection and in Table 4 for
patients who underwent bilateral neck dissections. Patients were
staged as pN according to the usual histopathologic criteria
(Hermanek et al, 1998) and mN according to CK19 mRNA real-
time RT–PCR results. The nodal status of 13 (45.2%) of 31 patients
(eight with unilateral neck dissection, five with bilateral neck
dissections) would therefore have been changed if the molecular
results were taken into account. Moreover, in nine of these 13
patients (five with unilateral neck dissection, four with bilateral
neck dissections), nodal status would have been upstaged from
pN0 to mN1, mN2b or mN2c, respectively (Hermanek et al, 1998).
In the 16 patients with lymph nodes metastases, analysis of the
pattern of carcinomatous spread within lymph node levels showed
that nodes from the IIa and IIb levels were free of metastatic cells
on pathologic examination in five (16% )of them: CK19 mRNA was
detected, while HES was negative in IIa and IIb lymph node levels
in two of those patients.
In the 64 lymph node levels showing CK19 mRNA expression,
the number of CK19 mRNA copies detected by real-time RT–PCR
was evaluated by the RQ calculation as shown in Figure 2. The
expression values of all histopathologically positive lymph node
levels ranged from 4.85 10
 4 to 4.15 10
 1, values that were
significantly higher than those for histologically negative lymph
Table 3 Results of histopathologic and molecular node status in patients
with unilateral neck dissection
Lymph node levels
c
Patients
age/gender Tumour sites pN
a mN
b Histopathology
a PCR
b
50/M Oral cavity 0 2b
d — Ia, IIb
57/M Hypopharynx 0 2b
d — IIa, IIb
75/M Oropharynx 0 0 — —
69/M Oropharynx 0 0 — —
52/M Hypopharynx 2 2a IIa IIa
58/M Hypopharynx 0 0 — —
73/M Oropharynx 0 2b
d — IIb, IV
74/M Hypopharynx 2b 2b IIa, IIb IIa, IIb
69/M Hypopharynx 2b 2b III III
50/F Oral cavity 1 2b
d IIa IIa, III
50/M Hypopharynx 1 1 IIa IIa
64/F Oropharynx 0 0 — —
54/M Hypopharynx 0 0 — —
41/M Hypopharynx 1 2b
d III IIa, IIb, III, IV
72/M Oropharynx 1 2b
d V IV, V
51/M Oral cavity 2b 2b Ib Ia, Ib, IIa, IIb
69/M Hypopharynx 0 0 — —
55/M Hypopharynx 2b 2b IIa, III IIa, III
64/M Oral cavity 0 1
d — IIb
61/M Oral cavity 0 2b
d — IIa, IIb
RT–PCR¼reverse transcriptase–polymerase chain reaction.
aPathologic lymph
node staging according to histopathologic examination; —indicates the absence of
detected carcinomatous cells.
bMolecular lymph node staging according to real-time
RT–PCR detection of CK19 mRNA.
cNeck dissection samples have been
categorised according to the topographic classification of the cervical lymph node
levels proposed by Robbins et al (2002).
dChange in nodal status according to real-
time RT–PCR CK19 results.
Table 4 Results of histopathologic and molecular node status in patients with bilateral neck dissections
Lymph node levels – R
c
Lymph node levels – L
c
Patients age/gender Tumour sites pN
a mN
b Histopathology
a PCR
b Histopathology
a PCR
b
61/M Oropharynx 2a 2b
d IIa IIa, IIb, III — —
66/F Hypopharynx 2c 2c IIa, IIb, III IIa, IIb, III IIa IIa, III, IV
68/M Hypopharynx 2b 2b IV, V IV, V — —
63/M Hypopharynx 0 2c
d — III, IV — IV
53/M Hypopharynx 2c 2c IIa IIa, IIb III III
64/F Larynx 0 0 — — — —
40/M Hypopharynx 2c 2c IIb, III IIb, III IIa, IIb IIa, IIb
55/M Oral Cavity 2b 2b — — Ib, IIa, IIb Ib, IIa, IIb
59/F Oral Cavity 0 2c
d — IIa, IIb, IV — IIb, III, IV
52/F Hypopharynx 0 2c
d — IIa, IV — IIa, IIb, IV
55/F Hypopharynx 0 1
d — — — IIb
RT–PCR¼reverse transcriptase–polymerase chain reaction.
aPathologic lymph node staging according to histopathologic examination; —indicates the absence of detected
carcinomatous cells.
bMolecular lymph node staging according to detection of CK19 mRNA by real-time RT–PCR.
cNeck dissection samples have been categorised prospectively
according to the topographic classification of cervical lymph node levels proposed by Robbins et al (2002) (R: right; L: left).
dChange in nodal status according to real-time
RT–PCR CK19 results.
1
0.1
0.01
0.001
0.0001
0.00001
HES positive HES negative
Real-time PCR positive Real-time PCR positive
(n=29 lymph node levels) (n=35 lymph node levels)
* P < 0.0001
*
Figure 2 RQ (relative quantification of CKmRNA copies) according to
the equation: RQ ¼ð 1 þ AEÞ
 DDCt of CK19 mRNA expression in 64
lymph node levels (29 histopathologically positive; 35 histopathologically
negative).
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snode levels, which ranged from 1.13 10
 5 to 1.42 10
 3
(Po0.0001).
Immunohistochemistry
In the 203 lymph nodes that were histopathologically negative but
CK19 mRNA positive on real-time RT–PCR, no carcinoma-
tous cell was immunodetected by IHC, while in all the five HES-
positive lymph nodes, carcinomatous cells were immunolabelled
(Figure 3).
DISCUSSION
Carcinomatous cell diffusion in cervical lymph nodes is a major
determinant of therapy and prognosis for patients with HNSCC
(Shores et al, 2004) as cure rates for patients with pathologically
metastatic lymph nodes drop to one-half of those of patients
without nodal involvement (Shah, 1990). As histopathologic
analysis of neck dissection specimens is usually performed on
several 3–4mm sections from each lymph node, and as
micrometastases represent tumour deposits measuring less than
2mm in diameter, they can be easily missed on routine light
microscopy (Hermanek et al, 1999; Genden et al, 2003). For
example, it has been reported that 21.9% of patients with cancer of
the oral cavity have micrometastases with an average diameter of
1.36mm (Hamakawa et al, 2000b).
Various molecular markers, as mRNA expressed in tumour cells,
particularly CK mRNAs, have therefore been investigated in order
to detect the presence of occult tumour cells in lymph nodes
(Shores et al, 2004). Previous studies using such markers in
HNSCC have suggested a low specificity (Kawamata et al, 1999;
Hamakawa et al, 2000a), particularly because of false-positive
results associated with benign epithelial rests in lymph nodes
found in 1.6% of cervical nodes, but only in lymph nodes from
level I (Gnepp, 2000; Hamakawa et al, 2000b). The assay used in
the present study, that is, RT–PCR detection of CK19 mRNA, has
been developed in our laboratory for the detection of occult
carcinomatous cells in mediastinal lymph nodes in non-small-cell
lung carcinoma (Saintigny et al, 2005) and by other teams in
various carcinomas (Van Trappen et al, 2001; Inokuchi et al, 2003;
Favia et al, 2004). The primers and probe for CK19 mRNA
detection were designed to avoid the detection of the two known
pseudogenes (Rund et al, 1999; Van Trappen et al, 2001; Saintigny
et al, 2005) and we used real-time RT–PCR with the Taqman
chemistry. All blood cell samples from healthy donors and lymph
nodes specimens collected from patients without cancer were
negative, while CK19 mRNA was detected in all samples from the
29 lymph node levels shown to be metastatic on histopathology.
We therefore consider that CK19 mRNA is a reliable marker for
carcinomatous cell detection in HNCC as in other carcinomas
(Van Trappen et al, 2001; Saintigny et al, 2005).
In this study, CK19 mRNA was detected in 35 of the 178 lymph
node levels that were free of tumour cells on histopathology.
Moreover, quantitative evaluation by the RQ of the amount of
CK19 mRNA clearly showed a significant difference between
histopathologically positive and negative lymph nodes. In a
previous study, using dilution of CAPAN-1 cells in blood
cells, we showed that the threshold of this method can be
considered to detect one tumour cell within 10
4 PBMNS (Saintigny
et al, 2005).
These data suggest that real-time RT–PCR could potentially
increase the sensitivity of routine pathological examination
(Becker et al, 2004; Ferris et al, 2005), and could therefore be
used routinely to examine all nodes removed during neck
dissection that are negative on standard histopathologic examina-
tion.
Clinically, although the prognostic significance of micrometa-
stases has not been established in HNSCC, a previous study
suggested that the presence of occult micrometastases increases
the risk of regional recurrence (Rhee et al, 2002). According
to Ferlito et al (2000), selective neck dissection in HNSCC
provides important information for prognostic purposes
and therapeutic decisions. In the present study, occult micro-
metastases were detected in 13 out of 31 patients, and if these
findings were taken into account, they would have changed
the patients’ nodal status and nine pN0 patients would have been
mN-upstaged.
According to the work of Rouvie `re (1938), the lymphatic
drainage of the head and neck region follows a relatively constant
and sequential route. Level II is the first node level in the majority
of HNSCC, but other levels are also likely to be the first node level,
especially in tumours of the oral cavity (level I) or hypopharynx
(level III) (Schauer et al, 2004). As a variable lymphatic drainage
in HNSCC can be observed, tumour cells may be missed in
unsuspected groups of lymph nodes (Byers et al, 1997). In our
study, this variability of lymphatic drainage was observed in five
out of 31 patients. In two of these patients, CK19 mRNA was
detected in IIa and IIb lymph node levels that were negative on
histopathology. In support of this idea, Mozzillo et al (2001)
recently noted a 18% incidence of sentinel nodes outside the
expected nodal drainage pattern, and Byers et al (1997) found that
15.8% of 277 patients with squamous cell carcinoma of the oral
tongue had skip metastases.
Serial sectioning and IHC have been extensively developed
for the detection of occult metastasis in HNCC and in a wide
range of solid tumours (Ambrosch and Brinck, 1996). This
method has the advantage of preserving cellular and tissue
morphological features, but is expensive and time-consuming,
and therefore cannot be used for most routine applications
(Becker et al, 2004). However, it has been demonstrated that it
does not allow a significantly higher detection rate than
histopathologic examination of HE-stained sections (Woolgar,
1999; Hamakawa et al, 2000b). In our study, immunodetection of
carcinomatous cells of the 203 nodes that were HES negative and
real-time RT–PCR positive was negative. However, the clinical
relevance of this detection, by real-time RT–PCR only, with
respect to prognosis and treatment needs to be investigated by
further clinical studies.
In conclusion, these results indicate that real-time RT–PCR
assay for the detection of CK19 mRNA is a sensitive and reliable
method for the detection of carcinomatous cells in lymph nodes in
patients with HNSCC. This type of method could be used to
reassess lymph node status according to occult lymphatic spread
in patients with HNSCC.
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Figure 3 Immunohistochemistry on lymph nodes containing carcinoma-
tous cells detected after HES staining (right) after incubation with an
anticytokeratin monoclonal antibody (left) (final magnification  400).
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